Fukuda Denshi
Corporate brand
UnclaimedFukuda Denshi is a Japanese medical-technology company with a history centered on electrocardiographs and a current portfolio that includes ECG, telemetry, and bedside monitoring products.
Last updated September 25, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Fukuda Denshi Co., Ltd. is a Japanese medical-technology company whose history and identity are closely associated with electrocardiographs (ECGs). The company’s own history describes its work as beginning with Japan’s first electrocardiograph and characterizes its development as closely tied to the history of the ECG. Its ECG story says the company was founded in 1939 by Takashi Fukuda and traces its focus to the development of electrocardiographs with medical specialists. The company’s historical product record includes ECG equipment developed across several generations, from early vacuum-tube and battery-operated instruments to direct-writing, transistorized, compact, and automated ECG systems. Its history also identifies early Japanese Holter products: a Holter system and a 24-hour Holter recorder produced in 1977. These examples show a longstanding emphasis on cardiac measurement and recording technology. The current official website presents Fukuda as a healthcare-technology provider focused on patient-first solutions. Featured products in the supplied material include the LX-1300 ECG, respiration, and SpO2 transmitter; DYNASCOPE DS-1200 and BDS-1001 bedside monitor systems; and the CardiMax FX-9800 electrocardiograph. The company’s described portfolio therefore spans cardiac diagnostics, patient telemetry, and bedside monitoring. The supplied material does not specify its full product range, sales markets, ownership, or headquarters, so those details are not asserted here.
History
Fukuda Denshi’s company history is presented by the company as closely bound to the development of electrocardiography in Japan. Its ECG history page states that the company was founded in 1939 by Takashi Fukuda and describes its path as focused on electrocardiographs, developed with the support of medical specialists. The company’s historical overview frames its early work as a contribution to the introduction of electrocardiography in Japan. The product chronology begins with early ECG development in the 1935–1949 period. The listed instruments include a vacuum-tube, battery-operated, photographic single-channel ECG and the AD-1, produced from 1949. The AD-1 is described as vacuum-tube and AC-operated, with a differential amplifier and photographic single-channel recording. In the 1950s, the RS-1, produced from 1951, used a differential amplifier and direct writing. The DR-1T, produced from 1959, is described as a compact, high-performance, semi-transistorized single-channel ECG. The 1960s brought further changes in recording method and electronics. The FCC-1, produced from 1968, used heat-pen writing and an all-transistor design. The DU-3S, also produced from 1968, was an all-transistor, three-channel ECG with a plug-in input circuit. In the following decade, the company’s listed products show a move toward automated analysis and longer-term cardiac recording. The ECP-100, produced from 1977, combined an ECG with a minicomputer as an automatic ECG analysis system. The company also identifies the SCM-240 as Japan’s first ECG Holter system and the SM-24 as Japan’s first Holter recorder, both produced from 1977. The SM-24 recorded ECG for 24 hours on cassette tape, while the SCM-240 enabled long-term playback and accelerated analysis. The official timeline continues into later decades, although the supplied history excerpt ends partway through its 1980–1989 section. One item in that section is the FCP-30, described as a compact automatic ECG analysis unit that could analyze an individual’s ECG and print patient and analysis information. The ECG story presents reproducible measurements and objective data as important attributes of electrocardiography, and describes the company’s long-running relationship with clinical specialists as part of its development history. Today, the company’s supplied homepage highlights ECG equipment alongside telemetry and bedside monitoring. Named examples are the CardiMax FX-9800 electrocardiograph, LX-1300 ECG/respiration/SpO2 transmitter, and DYNASCOPE DS-1200 and BDS-1001 bedside monitor systems. The available sources establish this product continuity and the company’s active web presence, but do not document its present ownership, leadership, headquarters, or geographic sales footprint.
- 1977
ECP-100 automatic ECG analysis system produced
- 1977
SCM-240 Holter system and SM-24 Holter recorder produced
- 1968
FCC-1 and DU-3S ECG models produced
- 1959
DR-1T compact semi-transistorized ECG produced
- 1951
RS-1 direct-writing ECG produced
- 1949
AD-1 ECG produced
- 1939
Fukuda Denshi founded by Takashi Fukuda
Products and positioning
Patient-first medical technology, with a longstanding specialization in electrocardiography and current offerings in cardiac diagnostics and patient monitoring.
LX-1300
A compact, lightweight transmitter for continuous ECG, respiration, and SpO2 monitoring.
DYNASCOPE DS-1200 System
A bedside monitor system described as an adaptive monitoring solution.
DYNASCOPE BDS-1001 System
A bedside monitor system described as consolidating functions for critical care.
CardiMax FX-9800
An electrocardiograph presented for advanced cardiac diagnostics.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/fukuda-denshi · Editorial policy · How profiles are compiled